Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cerebrolysin and IGF-1 LR3 Interaction: Monitor | Peptide Database

Compound Profiles Cerebrolysin Neuropeptide Preparation | Neurological Recovery IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.. IGF-1 LR3 Modified Growth Factor Analog | Muscle Growth Func

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Cerebrolysin

Neuropeptide Preparation | Neurological Recovery

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors..

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

Combined Organ Load

Frequently Asked Questions

Can I take Cerebrolysin with IGF-1 LR3?

Yes, but with caution. Additive neurotrophic pathway effects. Regular monitoring is advised.

Is Cerebrolysin and IGF-1 LR3 safe together?

Based on documented research, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Cerebrolysin and IGF-1 LR3?

Additive neurotrophic pathway effects. This assessment has 90% confidence and is based on documented research data.

How should I time Cerebrolysin and IGF-1 LR3?

Cerebrolysin has a half-life of Minutes (component-dependent; e.g., BDNF ~10 min) and IGF-1 LR3 has a half-life of 20-30 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Community Research

Join others researching IllumiNeuro Protocol — share findings, ask questions, and learn from real experiences IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination. Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.

Source: peptide-db.com ↗

Community Research

Join others researching Erythropoietin (EPO) — share findings, ask questions, and learn from real experiences Erythropoietin (EPO) is an essential glycoprotein hormone that stimulates red blood cell production. Naturally produced by the kidneys in response to low oxygen levels, recombinant human EPO is FDA-approved for treating anemia in chronic kidney disease and chemotherapy patients. EPO binding to receptors on bone marrow cells promotes survival and maturation of red blood cell precursors, increasing oxygen-carrying capacity. Due to performance-enhancing effects, it is banned in competitive sports. EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production. Under hypoxic stress, endogenous EPO production can increase up to 1000-fold, demonstrating the body's powerful oxygen-sensing regulatory system.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Clascoterone is available in two topical formulations targeting different indications. Winlevi (clascoterone cream 1%) is commercially available by prescription for acne vulgaris. Breezula (clascoterone solution 7.5%) is under regulatory review for androgenetic alopecia. Both formulations are designed for direct application to the affected area, where the compound acts locally before being metabolized to inactive cortexolone. Acne treatment (FDA-approved) Clascoterone 1% cream (Winlevi) Twice daily (morning and evening) Apply a thin layer to affected areas of the face after cleansing Androgenetic alopecia treatment (investigational) Clascoterone 7.5% solution (Breezula) Once daily Apply approximately 1mL to affected areas of the scalp

Source: peptide-db.com ↗
Side effects

Common Side Effects

Nausea (40-66%) Diarrhea (25-49%) Vomiting (15-41%) Slight heart rate increase (mean 2-5 bpm)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides